203 related articles for article (PubMed ID: 36402456)
21. Human allogeneic stem cell maintenance and differentiation in a long-term multilineage SCID-hu graft.
Fraser CC; Kaneshima H; Hansteen G; Kilpatrick M; Hoffman R; Chen BP
Blood; 1995 Sep; 86(5):1680-93. PubMed ID: 7655000
[TBL] [Abstract][Full Text] [Related]
22. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
[TBL] [Abstract][Full Text] [Related]
23. Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood.
Gorin NC; Piantadosi S; Stull M; Bonte H; Wingard JR; Civin C
J Hematother Stem Cell Res; 2002 Apr; 11(2):277-92. PubMed ID: 11983099
[TBL] [Abstract][Full Text] [Related]
24. A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic.
Laroye C; Thilly N; Gauthier M; Luc A; Latger-Cannard V; Eschwege V; Bensoussan D; Pochon C; Campidelli A; Rubio MT; D'Aveni M; Decot V
Cytotherapy; 2023 Aug; 25(8):877-884. PubMed ID: 37178096
[TBL] [Abstract][Full Text] [Related]
25. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow.
Barker JN; Krepski TP; DeFor TE; Davies SM; Wagner JE; Weisdorf DJ
Biol Blood Marrow Transplant; 2002; 8(5):257-60. PubMed ID: 12064362
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of a procedure to isolate viable bone marrow cells from the vertebrae of cadaveric organ donors for composite organ grafting.
Gorantla VS; Schneeberger S; Moore LR; Donnenberg VS; Zimmerlin L; Lee WP; Donnenberg AD
Cytotherapy; 2012 Jan; 14(1):104-13. PubMed ID: 21905958
[TBL] [Abstract][Full Text] [Related]
27. Pluripotent and myeloid-committed CD34+ subsets in hematopoietic stem cell allografts.
Theilgaard-Mönch K; Raaschou-Jensen K; Schjødt K; Heilmann C; Vindeløv L; Jacobsen N; Dickmeiss E
Bone Marrow Transplant; 2003 Dec; 32(12):1125-33. PubMed ID: 14647266
[TBL] [Abstract][Full Text] [Related]
28. Outcomes with allogeneic stem cell transplant using cryopreserved versus fresh hematopoietic progenitor cell products.
Wan BA; Lindo L; Mourad YA; Chung S; Forrest D; Kuchenbauer F; Nantel S; Narayanan S; Nevill T; Power M; Rodrigo J; Sanford D; Song K; Stubbins RJ; Sutherland H; Toze CL; White J; Roy C; Hay KA
Cytotherapy; 2024 May; ():. PubMed ID: 38819367
[TBL] [Abstract][Full Text] [Related]
29. A comparative study of CD34+ cells, CD34+ subsets, colony forming cells and cobblestone area forming cells in cord blood and bone marrow allografts.
Theilgaard-Mönch K; Raaschou-Jensen K; Heilmann C; Andersen H; Bock J; Russel CA; Vindeløv L; Jacobsen N; Dickmeiss E
Eur J Haematol; 1999 Mar; 62(3):174-83. PubMed ID: 10089895
[TBL] [Abstract][Full Text] [Related]
30. Double haploidentical hematopoietic stem cell transplantation results in successful engraftment of bone marrow from both donors without graft-versus-host or graft-versus-graft effects.
Biswas CS; Sauter CT; Bailey CP; Rittenberg D; Luo X; Panis MM; Budak-Alpdogan T; Grosso D; Flomenberg N; Alpdogan O
Biol Blood Marrow Transplant; 2012 Dec; 18(12):1808-18. PubMed ID: 23084958
[TBL] [Abstract][Full Text] [Related]
31. [Umbilical cord blood as a source of stem cells].
Bojanić I; Golubić Cepulić B
Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
[TBL] [Abstract][Full Text] [Related]
32. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
33. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
34. Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34
Bucar S; Branco ADM; Mata MF; Milhano JC; Caramalho Í; Cabral JMS; Fernandes-Platzgummer A; da Silva CL
Stem Cell Res Ther; 2021 Jul; 12(1):399. PubMed ID: 34256848
[TBL] [Abstract][Full Text] [Related]
35. Cryopreserved fetal human liver hematopoietic progenitor cells for repopulating immune-deficient mouse bone marrow.
Zhao J; Hao HN; Lyman WD
Isr Med Assoc J; 2002 Nov; 4(11):989-91. PubMed ID: 12489487
[TBL] [Abstract][Full Text] [Related]
36. Fractionated Infusion of Hematopoietic Progenitor Cells Does Not Improve Neutrophil Recovery or Survival in Allograft Recipients.
Tamari R; Brown S; Devlin SM; Kosuri S; Maloy MA; Ponce DM; Sauter C; Shaffer B; Dahi P; Young JW; Jakubowski A; Papadopoulos EB; Castro-Malaspina H; Perales MA; Giralt SA; Gyurkocza B
Transplant Cell Ther; 2021 Oct; 27(10):852.e1-852.e9. PubMed ID: 34214736
[TBL] [Abstract][Full Text] [Related]
37. Cryopreservation of Growth Factor-Mobilized Peripheral Blood Stem Cells Does Not Compromise Major Outcomes after Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience.
Connelly-Smith L; Gooley T; Roberts L; Mielcarek M; Linenberger M; Petersdorf E; Sandmaier BM; Milano F
Transplant Cell Ther; 2023 Nov; 29(11):700.e1-700.e8. PubMed ID: 37659695
[TBL] [Abstract][Full Text] [Related]
38. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
[TBL] [Abstract][Full Text] [Related]
39. Effect of Cryopreservation in Unrelated Bone Marrow and Peripheral Blood Stem Cell Transplantation in the Era of the COVID-19 Pandemic: An Update from the Japan Marrow Donor Program.
Kanda Y; Doki N; Kojima M; Kako S; Inoue M; Uchida N; Onishi Y; Kamata R; Kotaki M; Kobayashi R; Tanaka J; Fukuda T; Fujii N; Miyamura K; Mori SI; Mori Y; Morishima Y; Yabe H; Atsuta Y; Kodera Y
Transplant Cell Ther; 2022 Oct; 28(10):677.e1-677.e6. PubMed ID: 35803526
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Outcomes of Allogeneic Transplantation for Primary Myelofibrosis among Hematopoietic Stem Cell Source Groups.
Murata M; Takenaka K; Uchida N; Ozawa Y; Ohashi K; Kim SW; Ikegame K; Kanda Y; Kobayashi H; Ishikawa J; Ago H; Hirokawa M; Fukuda T; Atsuta Y; Kondo T
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1536-1543. PubMed ID: 30826464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]